Overview
| Ubiquitin | |
|---|---|
| Linkage | Function |
| K48 | Proteasomal degradation |
| K63 | Endocytosis, signaling, [autophagy](/entities/autophagy) |
| K11 | Cell cycle regulation |
| K27 | DNA damage response |
| K33 | Mitochondrial quality control |
| K29 | Lysosomal degradation |
| K6 | Mitochondrial dynamics |
| M1 (linear) | [NF-κB](/entities/nf-kb) signaling |
| Associated Diseases | ALS, ALZHEIMER, ALZHEIMER DISEASE, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS |
| KG Connections | 2864 edges |
Ubiquitin is a highly conserved 76-amino acid protein that covalently attaches to target proteins to mark them for various cellular fates.1Overview of the ubiquitin-proteasome systemOpen reference2Impairment of the ubiquitin-proteasome system in Alzheimer's diseases and other tauopathiesOpen reference This post-translational modification, called ubiquitination or ubiquitylation, is a fundamental regulatory mechanism controlling protein degradation, signaling, trafficking, and localization. Dysregulation of ubiquitin biology is central to many neurodegenerative diseases.
Structure and Biochemistry
Ubiquitin Molecule
-
Molecular weight: 8.5 kDa
-
Seven lysine residues (K6, K11, K27, K29, K33, K48, K63)
-
N-terminal methionine (M1)
-
C-terminal glycine (G76) for conjugation
E1-E2-E3 Enzymatic Cascade
E1 - Activating enzymes:
-
~2 enzymes in humans
-
ATP-dependent ubiquitin activation
-
Forms thioester bond with ubiquitin C-terminus
E2 - Conjugating enzymes:
-
~40 enzymes in humans
-
Receive ubiquitin from E1
-
Determine chain linkage type
E3 - Ligase enzymes:
-
600 enzymes in humans
-
Substrate recognition
-
Transfer ubiquitin to target proteins
Ubiquitin Chain Types
Homotypic Chains (Same Linkage)
Heterotypic Chains
-
Mixed linkage chains
-
Branched ubiquitin chains
-
More complex regulatory functions
The Ubiquitin-Proteasome System (UPS)
26S Proteasome Structure
-
20S core particle (α-rings + β-rings)
-
19S regulatory caps (6 ATPases)
-
Recognizes poly-K48 chains
-
Degrades ubiquitinated proteins
Degradation Process
-
Polyubiquitin chain recognition
-
Substrate unfolding
-
Translocation into 20S core
-
Proteolytic cleavage (β1, β2, β5)
-
Peptide release
Autophagy-Lysosome Pathway
Ubiquitin in Autophagy
-
Selective autophagy receptors (p62, OPTN, NDP52)
-
Recognize poly-K63 and K27 chains
-
Link cargo to autophagosomes
-
LC3 interaction domain (LIR)
Aggrephagy
-
Clearance of protein aggregates
-
p62/SQSTM1 as key receptor
-
Ubiquitin chain specificity
-
Impaired in neurodegeneration
Disease Relevance
Alzheimer’s Disease
-
Ubiquitinated tau tangles3Tau-driven ubiquitination and neurodegenerationOpen reference
-
Impaired proteasome function
-
p62 accumulation in plaques
-
Failed aggregate clearance
-
UPS dysfunction precedes symptoms
Parkinson’s Disease
-
LRRK2 mutations affect ubiquitination
-
Parkin E3 ligase dysfunction
-
PINK1-Parkin mitophagy impairment
-
Ubiquitinated Lewy bodies
-
G2019S LRRK2 alters autophagy
Amyotrophic Lateral Sclerosis
-
Ubiquitinated inclusions
-
Mutations in UBQLN2 (ubiquilin 2)
-
TDP-43 ubiquitination
-
Proteasome impairment
-
Autophagy dysfunction
Huntington’s Disease
-
Mutant huntingtin aggregates
-
Impaired UPS function
-
Ubiquitinated inclusion bodies
-
Autophagy compensation
-
Therapeutic targeting potential
Frontotemporal Dementia
-
Tau and TDP-43 pathology
-
Ubiquitin chain abnormalities
-
OPTN mutations
-
p62 accumulation
Quality Control Mechanisms
ER-Associated Degradation (ERAD)
-
Misfolded proteins in ER
-
Retrotranslocation
-
Ubiquitination by E3 ligases
-
Proteasomal degradation
Mitochondrial Quality Control
-
PINK1-Parkin mitophagy
-
Ubiquitin chains on mitochondria
-
Autophagy receptor recruitment
-
Mitochondrial dynamics
Nuclear Quality Control
-
Proteasomal degradation in nucleus
-
Chromatin-associated degradation
-
Histone ubiquitination
Therapeutic Approaches
Proteasome Enhancement
-
Natural compounds (EGCG, curcumin)
-
Proteasome activators
-
Overcoming inhibition
Autophagy Induction
-
mTOR inhibitors (rapamycin)
-
Trehalose
-
Exercise
-
Caloric restriction
E3 Ligase Modulation
-
Small molecule modulators
-
Gene therapy approaches
-
Specific ligase targeting
Deubiquitinating Enzymes (DUBs)
-
USP14 inhibition
-
OTUB1 enhancement
-
Proteasome-associated DUBs
Biomarkers
Protein Aggregation Markers
-
Ubiquitinated proteins in CSF
-
p62 levels
-
Serum ubiquitin
Activity Measures
-
Proteasome activity assays
-
Autophagic flux
-
Ubiquitin chain analysis
See Also
External Links
References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.